Search Results - "Medical oncology"

Emerging and Experimental Agents for Anal Cancer: What is New? by Farias JPF, Rangel da Silva MHC, Jácome AA

Connect to this object online.

Enzalutamide for the treatment of metastatic castration-resistant prostate cancer by Rodriguez-Vida A, Galazi M, Rudman S, Chowdhury S, Sternberg CN

Connect to this object online.

Increasing differential diagnosis between lipoma and liposarcoma through radiomics: a narrative review by Raffaele Natella, Giulia Varriano, Maria Chiara Brunese, Marcello Zappia, Michela Bruno, Michele Gallo, Flavio Fazioli, Igino Simonetti, Vincenza Granata, Luca Brunese, Antonella Santone

Connect to this object online.

Costs of adverse events associated with erlotinib or afatinib in first-line treatment of advanced EGFR-positive non-small cell lung cancer by Isla D, De Castro J, Juan O, Grau S, Orofino J, Gordo R, Rubio-Terrés C, Rubio-Rodríguez D

Connect to this object online.

Contrasting Immunopathogenic and Therapeutic Roles of Granulocyte Colony-Stimulating Factor in Cancer by Annette J. Theron, Helen C. Steel, Bernardo L. Rapoport, Ronald Anderson

Connect to this object online.

Current Opinion on Pixantrone in the Treatment of Non-Hodgkin B-Cell Lymphoma by Jezeršek Novaković B, Boltežar L, Novaković A

Connect to this object online.

A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia by Lickliter JD, Gan HK, Voskoboynik M, Arulananda S, Gao B, Nagrial A, Grimison P, Harrison M, Zou J, Zhang L, Luo S, Lahn M, Kallender H, Mannucci A, Somma C, Woods K, Behren A, Fernandez-Penas P, Millward M, Meniawy T

Connect to this object online.

Albumin-bound paclitaxel in solid tumors: clinical development and future directions by Kundranda MN, Niu J

Connect to this object online.

Inoperable Bowel Obstruction in Ovarian Cancer: Prevalence, Impact and Management Challenges by Gonzalez-Ochoa E, Alqaisi HA, Bhat G, Jivraj N, Lheureux S

Connect to this object online.

Biomarker and multigene assay testing in ER positive, HER-2 negative breast carcinomas: An international guidelines-based approach by Bradley M. Turner, Hani Katerji, Huina Zhang, David G. Hicks

Connect to this object online.

Current Insights on the Treatment of Anaplastic Lymphoma Kinase-Positive Metastatic Non-Small Cell Lung Cancer: Focus on Brigatinib by Rijavec E, Biello F, Indini A, Grossi F, Genova C

Connect to this object online.

Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy by Gerald HJ Mickisch, Björn Schwander, Bernard Escudier, et al

Connect to this object online.

A rare presentation of enfortumab vedotin-induced toxic epidermal necrolysis by Andrea Francis, BS, Antonio Jimenez, BS, Swaminathan Sundaresan, MD, Brent Kelly, MD

Connect to this object online.

Distress management in cancer patients：Guideline implementation based on CAN-IMPLEMENT by Liang Fu, Xiaoju Zhang, Yan Hu, Zhenqi Lu, Yang Yang, Mingzhu Huang, Yuanyuan Li, Fuzhong Zhu, Yang Wang, Zhe Huang

Connect to this object online.

Managing Pregnant Women with Hemophilia and von Willebrand Disease: How Do We Provide Optimum Care and Prevent Complications? by Janbain M, Kouides P

Connect to this object online.

Efficacy of BIBF 1120 or BIBF 1120 plus chemotherapy on nasopharyngeal carcinoma in vitro and in vivo by Xue C, Tian Y, Zhang J, Zhao Y, Zhan J, Fang W, Zhang L

Connect to this object online.

Contribution of capecitabine for therapy of patients with gastroesophageal cancer: an update of recent phase III results by Putao Cen, Eric D Tetzlaff, Jaffer A Ajani

Connect to this object online.

A Profile of Avelumab Plus Axitinib in the Treatment of Renal Cell Carcinoma by Tiako Meyo M, Chen J, Goldwasser F, Hirsch L, Huillard O

Connect to this object online.

Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer by De Luca R, Blasi L, Alù M, Gristina V, Cicero G

Connect to this object online.

In vitro and in vivo efficacy of afatinib as a single agent or in combination with gemcitabine for the treatment of nasopharyngeal carcinoma by Xue C, Tian Y, Zhang J, Zhao YY, Zhan JH, Fang WF, Zhang L

Connect to this object online.